Article

Ethnic Minorities Are "Silent Sufferers" of Chronic Fatigue Syndrome

Ethnicity, depression, lack of exercise or social support, and social difficulties are major risk factors for chronic fatigue syndrome.

New research published by BioMed Central’s open access journal BMC Medicine shows that ethnicity, depression, lack of exercise or social support, and social difficulties are major risk factors for chronic fatigue syndrome (CFS).

A multi-institute study funded by the Medical Research Council in the United Kingdom, involving researchers across London and Manchester, looked at data from over 4,000 adults living in England. The result of this study showed that, on average, there is a 2.3% risk of suffering from CFS and that risk increases with age by 2% per year from the age of 35. When the researchers compared the occurrence of CFS with medical factors and exercise they found that, while both depression and anxiety were associated with a much higher risk of CFS, moderate exercise halved the risk.

Social status and adversity were also major risk factors along with cultural and ethnic background. The incidence of CFS was highest amongst people who had the most difficulties with housing, finances, or had family problems, but this was balanced by levels of support within the community. Perceived cultural discrimination and insults in the workplace, or in society, along with racial and religious discrimination, were also much higher for CFS sufferers. Overall people with Pakistani, Indian, or Black Caribbean backgrounds had a greater risk of CFS than the white population.

“Earlier studies, based on attendance at clinics, indicated that CFS is a disease of white, middle class people, Kamaldeep Bhui, MD, of the Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, said in a statement. “Our results show that CFS is more common amongst the physically inactive, those with social difficulties and with poor social support, and ethnic minorities, especially in the Pakistani group studied, and that they are silently suffering.”

Related Videos
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
© 2024 MJH Life Sciences

All rights reserved.